Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough

Parkinson’s disease (PD) is the second most common neurodegenerative disorder of the elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed most commonly by clinical examination with a great degree of accuracy in specialized centers. However, in some cases, non-cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganguly, Upasana, Singh, Sukhpal, Pal, Soumya, Prasad, Suvarna, Agrawal, Bimal K., Saini, Reena V., Chakrabarti, Sasanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298029/
https://www.ncbi.nlm.nih.gov/pubmed/34305577
http://dx.doi.org/10.3389/fnagi.2021.702639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298029/
https://www.ncbi.nlm.nih.gov/pubmed/34305577
http://dx.doi.org/10.3389/fnagi.2021.702639

Ejemplares similares